article thumbnail

5 HIPAA Compliance Tips For Healthcare Professionals

Pharma Mirror

They won’t be at risk of losing their license. They can deal with other healthcare franchises, which also need compliance. There are more reasons why health professionals should have a HIPAA compliance program in their clinics and offices. Their patients would feel secure with them.

article thumbnail

How to Identify Branded Drugs with a Low Likelihood of Generic Entry as Targets for In-Licensing

Drug Patent Watch

Identifying branded drugs with a low likelihood of generic entry has become a crucial strategy for companies looking to expand their product portfolio through in-licensing. In this comprehensive guide, we’ll explore the intricacies of identifying such drugs and leveraging them for successful in-licensing opportunities.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The criticality of compliance

pharmaphorum

Prior to selling drugs or medical products in any country, pharmaceutical companies must prove compliance and gain the regulatory approval required by the country in which the goods will be distributed in. So, with mandates in place, how do manufacturing facilities meet these compliance goals? The dominion of data.

article thumbnail

Hidden compliance risks for life sciences companies

pharmaphorum

The life sciences history industry has some unique challenges when it comes to compliance. But if you think third party compliance risks are bad, don’t take your eye off fourth and fifth parties, says Allan Matheson. A decade ago, life sciences firms were early adopters of robust compliance technology — far ahead of other industries.

article thumbnail

AstraZeneca to deliver Covid-19 antibody therapy doses to Switzerland

Pharmaceutical Technology

In June 2020, these antibodies, discovered at Vanderbilt University Medical Center, were licensed to AstraZeneca. The drug combination is anticipated to be made available in August and could only be used in compliance with the necessary conditions of the Swiss Society of Infectious Diseases (SSI).

Antibody 264
article thumbnail

Oral COVID-19 vaccine beckons, as ImmunityBio licenses iosBio tech

pharmaphorum

ImmunityBio has licensed technology underpinning a COVID-19 vaccine that could be administered orally rather than by injection from UK biotech iosBio. They also offer the potential for self-administration at home rather than in a health setting, making compliance with booster dosage potentially higher.”.

Licensing 119
article thumbnail

What to Expect When you are Expecting…a Government Shutdown

FDA Law Blog

The answers below are based on my experience as a reviewer and compliance officer at FDA during the 5-week 2018/2019 government shutdown. Most of FDAs reviewers are exempt, while compliance, policy, and administrative support are typically furloughed. What does it mean for FDA staff?